bicalutamide and thymidine

bicalutamide has been researched along with thymidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belfiore, A; Frasca, F; Marcelli, M; Mineo, R; Pandini, G; Roberts, CT; Vigneri, R	1
Katayama, H; Murashima, T; Nishizawa, Y; Saeki, Y	1

Other Studies

2 other study(ies) available for bicalutamide and thymidine

Article	Year
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer research, 2005, Mar-01, Volume: 65, Issue:5 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cell Line, Tumor; Cell Movement; DNA; Enzyme Inhibitors; Humans; Insulin-Like Growth Factor I; Kidney; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptor, IGF Type 1; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thymidine; Tosyl Compounds; Transcription, Genetic; Up-Regulation	2005
The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines. International journal of oncology, 2010, Volume: 36, Issue:3 Topics: Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cyclin A; Fibroblast Growth Factor 8; Humans; Male; Mice; Nitriles; Prostatic Neoplasms; Testosterone; Thymidine; Tosyl Compounds	2010

Article

Year

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

Cancer research, 2005, Mar-01, Volume: 65, Issue:5

Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cell Line, Tumor; Cell Movement; DNA; Enzyme Inhibitors; Humans; Insulin-Like Growth Factor I; Kidney; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptor, IGF Type 1; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thymidine; Tosyl Compounds; Transcription, Genetic; Up-Regulation

2005

The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines.

International journal of oncology, 2010, Volume: 36, Issue:3

Topics: Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cyclin A; Fibroblast Growth Factor 8; Humans; Male; Mice; Nitriles; Prostatic Neoplasms; Testosterone; Thymidine; Tosyl Compounds

2010